These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 29209873

  • 1. 99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis.
    Wang J, Fan T, He Y, Chen X, Fan Z, Xie Y, Wang T, Li J, Ouyang T.
    Breast Cancer Res Treat; 2018 Apr; 168(2):365-370. PubMed ID: 29209873
    [Abstract] [Full Text] [Related]

  • 2. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ, Lin BH, Yang Z, Ouyang T, Li JF, Xu B, Zhang Y, Zhang MY.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [Abstract] [Full Text] [Related]

  • 3. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C, Graceffa G, La Mendola R, Fricano S, Fricano M, Vieni S.
    Ann Ital Chir; 2015 Mar; 86():497-502. PubMed ID: 26898168
    [Abstract] [Full Text] [Related]

  • 4. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
    Usmani S, Ahmed N, Al Saleh N, abu Huda F, Amanguno HG, Amir T, al Kandari F.
    Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
    [Abstract] [Full Text] [Related]

  • 5. Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients.
    Li N, Wang X, Lin B, Zhu H, Liu C, Xu X, Zhang Y, Zhai S, OuYang T, Li J, Yang Z.
    J Nucl Med; 2016 Aug; 57(8):1214-20. PubMed ID: 26985055
    [Abstract] [Full Text] [Related]

  • 6. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.
    Yang Y, He Y, Fan Z, Ouyang T.
    Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832
    [Abstract] [Full Text] [Related]

  • 7. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN, Amant F, Cardonick EH, Loibl S, Peccatori FA, Gheysens O, Sangalli CA, Nekljudova V, Steffensen KD, Mhallem Gziri M, Schröder CP, Lok CAR, Verest A, Neven P, Smeets A, Pruneri G, Cremonesi M, Gentilini O, International Network on Cancer, Infertility and Pregnancy.
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [Abstract] [Full Text] [Related]

  • 8. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
    Liang Y, Chen X, Tong Y, Zhan W, Zhu Y, Wu J, Huang O, He J, Zhu L, Li Y, Chen W, Shen K.
    World J Surg Oncol; 2019 Feb 20; 17(1):37. PubMed ID: 30786903
    [Abstract] [Full Text] [Related]

  • 9. Comparative research on 99mTc-Rituximab and 99mTc-sulfur colloid in sentinel lymph node imaging of breast cancer.
    Zhang JJ, Zhang WC, An CX, Li XM, Ma L.
    BMC Cancer; 2019 Oct 15; 19(1):956. PubMed ID: 31615471
    [Abstract] [Full Text] [Related]

  • 10. Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
    Osorio-Silla I, Gómez Valdazo A, Sánchez Méndez JI, York E, Díaz-Almirón M, Gómez Ramírez J, Rivas Fidalgo S, Oliver JM, Álvarez CM, Hardisson D, Díaz Miguel M, Lobo F, Díaz Domínguez J.
    Ann R Coll Surg Engl; 2019 Mar 15; 101(3):186-192. PubMed ID: 30421628
    [Abstract] [Full Text] [Related]

  • 11. Axillary management and long-term oncologic outcomes in breast cancer patients with clinical N1 disease treated with neoadjuvant chemotherapy.
    Sparger CC, Hernandez AE, Rojas KE, Khan K, Halfteck GG, Möller M, Avisar E, Goel N, Crystal JS, Kesmodel SB.
    World J Surg Oncol; 2024 Jul 29; 22(1):199. PubMed ID: 39075403
    [Abstract] [Full Text] [Related]

  • 12. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H, Nishina M, Yasui D, Hirata T, Ozaki S.
    World J Surg Oncol; 2019 Feb 23; 17(1):41. PubMed ID: 30797231
    [Abstract] [Full Text] [Related]

  • 13. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.
    Matsen C, Villegas K, Eaton A, Stempel M, Manning A, Cody HS, Morrow M, Heerdt A.
    Ann Surg Oncol; 2016 Aug 23; 23(8):2456-61. PubMed ID: 26957506
    [Abstract] [Full Text] [Related]

  • 14. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
    Liu YL, Kuo WL, Lo YF, Tsai HP, Shen SC, Yu CC, Chou HH, Chu CH, Chen SC.
    Biomed J; 2022 Apr 23; 45(2):396-405. PubMed ID: 35562283
    [Abstract] [Full Text] [Related]

  • 15. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
    van Wely BJ, van den Wildenberg FJ, Gobardhan P, van Dalen T, Borel Rinkes IH, Theunissen EB, Wijsman JH, Ernst M, van der Pol CC, Madsen EV, Vles WJ, Wauters CA, de Wilt JH, Strobbe LJ.
    Eur J Surg Oncol; 2012 Oct 23; 38(10):925-31. PubMed ID: 22633152
    [Abstract] [Full Text] [Related]

  • 16. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ, McAuliffe PF, Soran A, McGuire KP, Johnson RR, Bonaventura M, Ahrendt GM.
    Ann Surg Oncol; 2016 May 23; 23(5):1549-53. PubMed ID: 26727919
    [Abstract] [Full Text] [Related]

  • 17. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
    Sekine C, Nakano S, Mibu A, Otsuka M, Oinuma T, Takeyama H.
    Asian J Surg; 2020 Jan 23; 43(1):148-153. PubMed ID: 31153730
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
    Bulte JP, van Wely BJ, Kasper S, Kuijt G, van den Wildenberg FJ, Strobbe LJ, de Wilt JH.
    Breast Cancer Res Treat; 2013 Jul 23; 140(1):143-9. PubMed ID: 23793602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.